Supernus Pharmaceuticals, Inc. recalls
Every recall we track for Supernus Pharmaceuticals, Inc. — 3 in all, from 2016–2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
2 recalls since 2017.
All FDA recall records for Supernus Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 1 | 1 | 2 |
Supernus Pharmaceuticals, Inc. recalls before 2017
Recalls on record by year.
What to do if you have a recalled Supernus Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Supernus Pharmaceuticals, Inc. recalls
3 shown- Lower riskDrug
Supernus Pharmaceuticals, Inc. recalls Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma
Supernus Pharmaceuticals recalls Trokendi XR 50mg extended-release capsules due to failed dissolution specifications. This may affect safety and requires checking product details.
Supernus PharmaceuticalsAug 31, 2026 - UnratedDrug
Supernus Pharmaceuticals, Inc. recalls Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma
Supernus Pharmaceuticals recalls Trokendi XR 25mg capsules due to failed dissolution specifications. This may affect safety and requires checking lot numbers.
Supernus PharmaceuticalsJul 6, 2026 - Use cautionDrug
Supernus Pharmaceuticals, Inc. recalls Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent
Supernus Pharmaceuticals recalls Trokendi XR 50mg capsules due to assay specification failures. Check lot #426636, exp 4/22/18.
Trokendi XRJul 12, 2016
Supernus Pharmaceuticals, Inc. recall questions
How many recalls has Supernus Pharmaceuticals, Inc. had?
3 recalls from Supernus Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2016–2026.
What is the most recent Supernus Pharmaceuticals, Inc. recall?
Supernus Pharmaceuticals, Inc. recalls Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma, dated Aug 31, 2026. Every Supernus Pharmaceuticals, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Supernus Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Supernus Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.